Rate My Professor John Carib Gensel

Gensel's research centers on the biological mechanisms regulating CNS macrophages—endogenous microglia and blood-borne monocytes—activated by central nervous system trauma, particularly in spinal cord and brain injury models. His studies address inducing pro-reparative macrophage phenotypes via therapeutic interventions, manipulating receptor pathways after injury, characterizing macrophage responses to traumatic brain injury, and examining age effects on neuroinflammatory responses to develop translatable therapies. He has produced 89 research outputs, including peer-reviewed articles such as "Assessment of Cerebrospinal Fluid and Blood-Based Biomarkers in Degenerative Cervical Myelopathy: Systematic Review and Meta-Analysis" (2026, Global Spine Journal), "In Vivo Telemetry to Record Long-Term Cardiovascular Parameters, Temperature, and Activity in Spinal Cord Injury Rat Models" (2026, Journal of Visualized Experiments), "Liposome-encapsulated clodronate and COX-2 inhibitor treatment impair ventilatory recovery but improve compensatory locomotor function following cervical spinal cord injury in rats" (2026, Experimental Neurology), "A Community Effort to Develop Common Data Elements for Pre-Clinical Spinal Cord Injury Research" (2025, Neurotrauma Reports), and "Complete High Thoracic Spinal Cord Injury Causes Bowel Dysfunction in Mice" (2025, Journal of Neurotrauma). Gensel has received research grants since 2014, including a $1.6 million NINDS award in 2015, and honors such as the Charles T. Wethington Excellence in Research Award (2013-2022) and the Office of Biomedical Education Excellent Mentor Award (2021). As principal investigator on funded projects from Novoron Bioscience, Wings for Life Spinal Cord Research Foundation, and Craig H. Neilsen Foundation, his contributions advance neurotrauma repair strategies.